
    
      Patients with acute sinusitis were randomly assigned (1:1) to receive either cefetamet (500
      mg twice daily, study group) or cefdinir (100 mg three times a day, control group) and
      corresponding placebo t.i.d. or b.i.d. for 2 weeks.
    
  